All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-37107785

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	37107785	D614G	S	S	COVID-19	G R S L	View
2	37107785	D681R	S	S	COVID-19	G R S L	View
3	37107785	D950N	S	S	COVID-19	G R S L	View
4	37107785	E484K	S	S	COVID-19	G R S L	View
5	37107785	E484N	S	S	COVID-19	G R S L	View
6	37107785	G142D	S	S	COVID-19	G R S L	View
7	37107785	G339D	S	S	COVID-19	G R S L	View
8	37107785	H655Y	S	S	COVID-19	G R S L	View
9	37107785	L452R	S	S	COVID-19	G R S L	View
10	37107785	N501Y	S	S	COVID-19	G R S L	View
11	37107785	P681H	S	S	COVID-19	G R S L	View
12	37107785	P681R	S	S	COVID-19	G R S L	View
13	37107785	Q493R	S	S	COVID-19	G R S L	View
14	37107785	R346K	S	S	COVID-19	G R S L	View
15	37107785	T19R	S	S	COVID-19	G R S L	View
16	37107785	T274T	S	S	COVID-19	G R S L	View
17	37107785	T474K	S	S	COVID-19	G R S L	View
18	37107785	T478K	S	S	COVID-19	G R S L	View
19	37107785	T95I	S	S	COVID-19	G R S L	View
20	37107785	Y145N	S	S	COVID-19	G R S L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.